Liver metastasis is a primary factor of prognosis and long-term survival for patients diagnosed with colorectal cancer (CRC). Colorectal cancer liver metastasis (CRCLM), is a complex biological process involving multiple factors and steps, and its mechanisms are yet to be discovered. In recent years, small noncoding RNAs, especially microRNAs (miRNAs) have been proven to play an important role in tumorigenesis, progression and metastasis in a variety of cancers, including CRC. Increasing evidence suggests that miRNAs, including those from exosomes secreted by tumor cells in circulation, could be used as promising biomarkers in early cancer detection, treatment, and prognosis. In this review, we focus on the functional roles and clinical applications of miRNAs, especially those from circulating exosomes secreted by tumor cells related to CRCLM.
CITATION STYLE
Huang, S., Tan, X., Huang, Z., Chen, Z., Lin, P., & Fu, S. W. (2018). MicroRNA biomarkers in colorectal cancer liver metastasis. Journal of Cancer, 9(21), 3867–6873. https://doi.org/10.7150/jca.28588
Mendeley helps you to discover research relevant for your work.